Silencing of p53 by siRNA transfection

SD Sergey A. Dyshlovoy
RM Ramin Madanchi
JH Jessica Hauschild
KO Katharina Otte
WA Winfried H. Alsdorf
US Udo Schumacher
VK Vladimir I. Kalinin
AS Alexandra S. Silchenko
SA Sergey A. Avilov
FH Friedemann Honecker
VS Valentin A. Stonik
CB Carsten Bokemeyer
GA Gunhild von Amsberg
request Request a Protocol
ask Ask a question
Favorite

Silencing of p53 gene was performed using siRNA transfection technique and Lipofectamine® RNAiMAX Transfection Reagent (Invitrogen, UK). RT112 cells were pre-incubated overnight in 6-well plates (1 × 105 cells/well in 2 mL) in antibiotics-free RPMI media. The solutions (a) and (b) were prepared: (a) 20 μL of 100 pmol/μL siRNA (total amount 2 nmol) + 230 μL of Opti-MEM media; (b) 7.5 μL of Lipofectamine® RNAiMAX Transfection Reagent + 242.5 μL of Opti-MEM media. The solutions were incubated for 5 min, mixed and further incubated for 20 min. The media in the wells were replaced with 2 mL of fresh antibiotics-free RPMI media and 0.5 mL of (a) + (b) mixture were added to each well by dropping. After 72 h of incubation the media was aspirated, cells were washed PBS, and fresh antibiotics-free RPMI media (drug-containing or drug-free) was added (2 mL/well). Then the cells were either immediately harvested for Western blotting analysis or incubated for 48 h and analyzed by FACS.

Duplexed siRNA were purchased from Eurofins Genomics (Ebersberg, Germany). The gene target sequences (5′ → 3′) are: p53 siRNA (NM_000546_Val): GACUCCAGU GGUAAUCUAC(dTdT); scrambled siRNA (Non Specific Control 47% GC): AGGUAGUGUAAUCGCCUUG(dTdT).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A